Cardiff Oncology to Present at Upcoming Investor Conferences in September
- Tuesday, September 5, 2023, 7:01
- Finance
- Add a comment
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers, today announced that company management will…
About the Author
adminasapcorp has written 41546 stories on this site.